IMPACT FACTOR JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOGS LaTeX 5G Tutorial Advertise
 

Search About Journals, Conferences, and Book Series


Expert Opinion on Emerging Drugs- Impact Factor, Overall Ranking, h-index, SJR, Rating, Publisher, ISSN, and Other Important Metrics

Last Updated on October 4, 2021

Impact Factor

4.191

h-Index

 48

Rank

 4538

SJR

 0.975

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics

Title Expert Opinion on Emerging Drugs
Abbreviation Expert Opin. Emerg. Drugs
Publication Type Journal
Subject Area, Categories, Scope Pharmacology (Q2); Pharmacology (medical) (Q2)
h-index 48
Overall Rank/Ranking 4538
SCImago Journal Rank (SJR) 0.975
Impact Score 3.58
Impact Factor 4.191 (2020)
Publisher Taylor and Francis Ltd.
Country United Kingdom
ISSN 14728214, 17447623


About Expert Opinion on Emerging Drugs


Expert Opinion on Emerging Drugs is a journal covering the technologies/fields/categories related to Pharmacology (Q2); Pharmacology (medical) (Q2). It is published by Taylor and Francis Ltd.. The overall rank of Expert Opinion on Emerging Drugs is 4538. According to SCImago Journal Rank (SJR), this journal is ranked 0.975. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 48. The best quartile for this journal is Q2.

The ISSN of Expert Opinion on Emerging Drugs journal is 14728214, 17447623. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Expert Opinion on Emerging Drugs is cited by a total of 267 articles during the last 3 years (Preceding 2020).


Expert Opinion on Emerging Drugs Impact Factor 2020-2021


The impact factor (IF) 2020 of Expert Opinion on Emerging Drugs is 4.191, which is computed in 2021 as per it's definition. Expert Opinion on Emerging Drugs IF is increased by a factor of 1.38 and approximate percentage change is 49.31% when compared to preceding year 2019, which shows a rising trend. The impact factor (If), also denoted as Journal impact factor (JIF), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Web of Science data.

Table Setting

Impact Factor Trend


Year wise Impact Factor (IF) of Expert Opinion on Emerging Drugs. Based on Web of Science data.


Year Impact Factor (IF)
2021/2022Coming Soon
2020 4.191
2019 2.807
2018 3.230
2017 3.579
2016 3.062
2015 2.120
2014 3.058
2013 3.284
2012 2.483
2011 3.207
2010 3.284

Expert Opinion on Emerging Drugs Impact Score 2020-2021


The impact score (IS) 2020 of Expert Opinion on Emerging Drugs is 3.58, which is computed in 2021 as per its definition. Expert Opinion on Emerging Drugs IS is increased by a factor of 0.72 and approximate percentage change is 25.17% when compared to preceding year 2019, which shows a rising trend. The impact score (IS), also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Expert Opinion on Emerging Drugs Impact Score 2021 Prediction


IS 2020 of Expert Opinion on Emerging Drugs is 3.58. If the same upward trend persists, impact score of joule may rise in 2021 as well.


Impact Score Trend


Year wise Impact Score (IS) of Expert Opinion on Emerging Drugs. Based on Scopus data.


Year Impact Score (IS)
2021/2022 Coming Soon
2020 3.58
2019 2.86
2018 2.94
2017 3.34
2016 3.14
2015 2.56
2014 3.13

Expert Opinion on Emerging Drugs h-index


  Table Setting

Expert Opinion on Emerging Drugs has an h-index of 48. It means 48 articles of this journal have more than 48 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Expert Opinion on Emerging Drugs ISSN


The ISSN of Expert Opinion on Emerging Drugs is 14728214, 17447623. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Expert Opinion on Emerging Drugs Rank and SCImago Journal Rank (SJR)


The overall rank of Expert Opinion on Emerging Drugs is 4538. According to SCImago Journal Rank (SJR), this journal is ranked 0.975. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Expert Opinion on Emerging Drugs Publisher


Table Setting

Expert Opinion on Emerging Drugs is published by Taylor and Francis Ltd.. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2000-2020. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Expert Opinion on Emerging Drugs is Expert Opin. Emerg. Drugs. This abbreviation ('Expert Opin. Emerg. Drugs') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Expert Opinion on Emerging Drugs


If your research field is/are related to Pharmacology (Q2); Pharmacology (medical) (Q2), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Factor, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Estudos Internacionais journal 28230 Editora PUC-Minas 2 0.18
IES 2019 - International Electronics Symposium: The Role of Techno-Intelligence in Creating an Open Energy System Towards Energy Democracy, Proceedings conference and proceedings 27149 4 0.60
Journal of Settlements and Spatial Planning journal 19029 Cluj University Press 6 0.48
EMBO Molecular Medicine journal 298 Wiley-Blackwell 107 8.92
Communications in Mathematical Sciences journal 6609 International Press of Boston, Inc. 50 1.78
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology journal 1145 John Wiley and Sons Inc. 72 9.42
2018 1st Workshop on Wide Bandgap Power Devices and Applications in Asia, WiPDA Asia 2018 conference and proceedings 21472 3 0.52
2019 IEEE Data Science Workshop, DSW 2019 - Proceedings conference and proceedings 19373 4 1.05
Cultures et Conflits journal 21031 Editions l'Harmattan 3 0.35
Kidney International journal 499 Elsevier Inc. 276 4.85

Check complete list



Year wise Impact Factor (IF) of Expert Opinion on Emerging Drugs

Impact Factor Table

Year Impact Factor (IF)
2021/2022Coming Soon
2020 4.191
2019 2.807
2018 3.230
2017 3.579
2016 3.062
2015 2.120
2014 3.058
2013 3.284
2012 2.483
2011 3.207
2010 3.284



Year wise Impact Score (IF) of Expert Opinion on Emerging Drugs

Impact Score Table

Year Impact Score (IS)
2021/2022 Coming Soon
2020 3.58
2019 2.86
2018 2.94
2017 3.34
2016 3.14
2015 2.56
2014 3.13



Top Journals/Conferences in Pharmacology

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Journal for ImmunoTherapy of Cancer
BioMed Central Ltd. | United Kingdom

Annual Review of Pharmacology and Toxicology
Annual Reviews Inc. | United States

Drug Resistance Updates
Churchill Livingstone | United States

Trends in Pharmacological Sciences
Elsevier Ltd. | United Kingdom

Molecular Therapy
Cell Press | United States

Pharmacology and Therapeutics
Elsevier Inc. | United States

Cell Chemical Biology
Elsevier Inc. | United States

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

See All

Top Journals/Conferences in Pharmacology (medical)

Drug Resistance Updates
Churchill Livingstone | United States

Pharmacology and Therapeutics
Elsevier Inc. | United States

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

American Journal of Transplantation
Wiley-Blackwell Publishing Ltd | United Kingdom

npj Breast Cancer
Nature Publishing Group | United Kingdom

npj Vaccines
Nature Publishing Group | United Kingdom

Neurotherapeutics
Springer New York | United States

ACS Pharmacology and Translational Science
American Chemical Society | United States

Journal of Biomedical Science
BioMed Central Ltd. | United Kingdom

Journal of acquired immune deficiency syndromes (1999)
Lippincott Williams and Wilkins Ltd. | United States

See All